These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9250256)

  • 1. Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist.
    Grossman J; Faiferman I; Dubb JW; Tompson DJ; Busse W; Bronsky E; Montanaro A; Southern L; Tinkelman D
    J Asthma; 1997; 34(4):321-8. PubMed ID: 9250256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.
    Yoo SH; Park SH; Song JS; Kang KH; Park CS; Yoo JH; Choi BW; Hahn MH;
    Respirology; 2001 Mar; 6(1):15-21. PubMed ID: 11264758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide clinical experience with the first marketed leukotriene receptor antagonist.
    Barnes NC; de Jong B; Miyamoto T
    Chest; 1997 Feb; 111(2 Suppl):52S-60S. PubMed ID: 9042027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
    Nakamura Y; Hoshino M; Sim JJ; Ishii K; Hosaka K; Sakamoto T
    Thorax; 1998 Oct; 53(10):835-41. PubMed ID: 10193369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
    Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM
    J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast.
    Shimbo J; Onodera O; Tanaka K; Tsuji S
    Clin Rheumatol; 2005 Nov; 24(6):661-2. PubMed ID: 15578247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
    Takahashi N; Iwanaga T; Aizawa H; Koto H; Watanabe K; Kishikawa R; Ikeda T; Shoji S; Nishima S; Hara N
    Intern Med; 2001 Aug; 40(8):791-4. PubMed ID: 11518127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma.
    Asano K; Shiomi T; Hasegawa N; Nakamura H; Kudo H; Matsuzaki T; Hakuno H; Fukunaga K; Suzuki Y; Kanazawa M; Yamaguchi K
    Pharmacogenetics; 2002 Oct; 12(7):565-70. PubMed ID: 12360108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists.
    Tomari S; Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Kawano T; Matsuo N; Kohno S
    Respiration; 2008; 76(4):398-402. PubMed ID: 18689991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pranlukast on bronchial inflammation in patients with asthma.
    Yoshida S; Ishizaki Y; Shoji T; Onuma K; Nakagawa H; Nakabayashi M; Akahori K; Hasegawa H; Amayasu H
    Clin Exp Allergy; 2000 Jul; 30(7):1008-14. PubMed ID: 10848924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
    Yokoyama A; Kohno N; Sakai K; Hirasawa Y; Kondo K; Hiwada K
    J Asthma; 1998; 35(1):57-62. PubMed ID: 9513583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics.
    Asano K; Nakade S; Shiomi T; Nakajima T; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Fujita H; Tanigawara Y; Ishizaka A
    Respirology; 2009 Aug; 14(6):822-7. PubMed ID: 19703064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.
    Okubo K; Hashiguchi K; Takeda T; Baba K; Kitagoh H; Miho H; Tomomatsu H; Yamaguchi S; Odani M; Yamamotoya H
    Allergy; 2017 Oct; 72(10):1565-1575. PubMed ID: 28378369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.